Pregnancy and neonatal outcomes of hyperglycemia caused by atosiban administration during pregnancy
It is known that atosiban has fewer side effects than conventional tocolytics. In clinical practice, however, hyperglycemia can be commonly observed in mothers who have been administered atosiban. Therefore, we investigated whether intravenous atosiban injection actually causes hyperglycemia and how...
Main Authors: | Hyun Jin Ko, Seong Yeon Hong, Jin Young Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2021-04-01
|
Series: | Clinical and Experimental Obstetrics & Gynecology |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/CEOG/48/2/10.31083/j.ceog.2021.02.2364 |
Similar Items
-
COMPAREMENT OF LOCALIZA ATOSIBAN AND HEXOPRENALINE IN PREMATURE DELIVERY BEFORE 32 AND AFTER 32 WEEKS OF PREGNANCY
by: O. R. Baev, et al.
Published: (2017-10-01) -
Use of Atosiban in a Twin Pregnancy With Extremely Preterm Premature Rupture in the Membrane of one Twin: A Case Report and Literature Review
by: Ming-Yih Wu, et al.
Published: (2010-12-01) -
Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis
by: Chih-Wei Lin, et al.
Published: (2023-07-01) -
Atosiban-induced acute pulmonary edema: A rare but severe complication of tocolysis
by: Zuwei Yang, et al.
Published: (2023-05-01) -
Comparison of terbutaline and atosiban as tocolytic agents in intrauterine repair of myelomeningocele: a retrospective cohort study
by: Shirley Andrade Santos, et al.
Published: (2024-05-01)